๐Ÿ‘‘
Volume Leader:Prognosis / Survival (20,740 papers)
๐Ÿš€
2-Year Surge Leader:Ferroptosis (+36.7% share growth)
๐Ÿ”ฅ
Clinical AI Surge:Machine Learning & AI (+24.5%, 9.37% share)
Jan 2024 โ€“ Sep 2026 ยท latest month may be partial
Prognosis & Survival AnalysisClinical Informatics & Prognosis
923
Jan 2024Sep 2026
Nanoparticles & Drug DeliveryDelivery & Formulation
558
Jan 2024Sep 2026
Biomarkers & Disease ProfilingClinical Diagnostics
653
Jan 2024Sep 2026
Machine Learning & AI Clinical Informatics & Prognosis
565
Jan 2024Sep 2026
Type 2 Diabetes Metabolic & Endocrine
398
Jan 2024Sep 2026
Molecular Docking & SARTargeted Therapeutics & Chemistry
434
Jan 2024Sep 2026
Kinase Inhibitors & Targeted TherapyTargeted Therapeutics & Chemistry
293
Jan 2024Sep 2026
Cancer ImmunotherapyOncology & Immunotherapy
495
Jan 2024Sep 2026
Obesity & Bariatric SurgeryMetabolic & Endocrine
263
Jan 2024Sep 2026
Antimicrobial & Bioactive AgentsInfectious Disease & Pharmacology
360
Jan 2024Sep 2026
Hydrogels & Wound HealingDelivery & Formulation
315
Jan 2024Sep 2026
Cardiovascular & Heart FailureCardiovascular & Metabolic
225
Jan 2024Sep 2026
Pediatric Clinical ResearchHealthcare & Outcomes
263
Jan 2024Sep 2026
Surveys & Public HealthHealthcare & Outcomes
271
Jan 2024Sep 2026
Patient Quality of Life (QoL)Healthcare & Outcomes
212
Jan 2024Sep 2026
Lung Cancer Oncology & Immunotherapy
171
Jan 2024Sep 2026
Stroke & Vascular RiskCardiovascular & Metabolic
158
Jan 2024Sep 2026
Neurodegenerative & DementiaNeurology & Aging
182
Jan 2024Sep 2026
Colorectal Cancer Oncology & Immunotherapy
133
Jan 2024Sep 2026
Ferroptosis & Cell DeathMechanisms & Cell Biology
94
Jan 2024Sep 2026
Myocardial InfarctionCardiovascular & Metabolic
53
Jan 2024Sep 2026
ChemoradiotherapyOncology & Immunotherapy
36
Jan 2024Sep 2026
Proteasome ComplexTargeted Therapeutics & Chemistry
31
Jan 2024Sep 2026
Pulmonary EmbolismCardiovascular & Metabolic
22
Jan 2024Sep 2026

Each line counts the keyword's papers that carry that sub-term. A paper can carry several, so the lines need not add up to the keyword, shown in gray.

    Table view
    Table view
    KeywordCategoryAvg monthly sharePeak monthMatching papers
    Prognosis & Survival AnalysisClinical Informatics & Prognosis17.09%Sep 2026 (20.92%)20,919
    Nanoparticles & Drug DeliveryDelivery & Formulation13.83%Oct 2025 (15.94%)16,661
    Biomarkers & Disease ProfilingClinical Diagnostics11.78%Jul 2026 (11.6%)14,491
    Machine Learning & AIClinical Informatics & Prognosis8.46%Jul 2026 (10.04%)10,500
    Type 2 DiabetesMetabolic & Endocrine7.97%Jan 2026 (11.37%)9,602
    Molecular Docking & SARTargeted Therapeutics & Chemistry6.97%Sep 2026 (9.84%)8,509
    Kinase Inhibitors & Targeted TherapyTargeted Therapeutics & Chemistry6.41%Apr 2026 (6.4%)7,739
    Cancer ImmunotherapyOncology & Immunotherapy6.39%Apr 2026 (10.81%)7,893
    Obesity & Bariatric SurgeryMetabolic & Endocrine6.16%Dec 2025 (7.51%)7,422
    Antimicrobial & Bioactive AgentsInfectious Disease & Pharmacology6.06%Aug 2026 (6.8%)7,439
    Hydrogels & Wound HealingDelivery & Formulation5.10%Jul 2026 (5.6%)6,238
    Cardiovascular & Heart FailureCardiovascular & Metabolic5.04%Sep 2026 (5.1%)6,116
    Pediatric Clinical ResearchHealthcare & Outcomes4.80%Sep 2026 (5.96%)5,890
    Surveys & Public HealthHealthcare & Outcomes4.13%Jul 2026 (4.81%)5,092
    Patient Quality of Life (QoL)Healthcare & Outcomes3.40%Jul 2026 (3.77%)4,196
    Lung CancerOncology & Immunotherapy3.33%Jul 2026 (3.04%)4,064
    Stroke & Vascular RiskCardiovascular & Metabolic2.82%Jul 2026 (2.81%)3,449
    Neurodegenerative & DementiaNeurology & Aging2.60%Jul 2026 (3.23%)3,233
    Colorectal CancerOncology & Immunotherapy2.12%Sep 2026 (3.01%)2,627
    Ferroptosis & Cell DeathMechanisms & Cell Biology1.36%Jul 2026 (1.67%)1,684
    Myocardial InfarctionCardiovascular & Metabolic0.99%Sep 2026 (1.2%)1,194
    ChemoradiotherapyOncology & Immunotherapy0.44%Sep 2026 (0.82%)546
    Proteasome ComplexTargeted Therapeutics & Chemistry0.43%Sep 2026 (0.7%)533
    Pulmonary EmbolismCardiovascular & Metabolic0.39%Sep 2025 (0.63%)472